Staar Surgical 

$28.56
-$0.43-1.48% Friday 20:00

统计数据

当日最高
30.2
当日最低
28.37
52周最高
52.68
52周最低
26.66
成交量
619,755
平均成交量
834,020
市值
1.63B
市盈率
100.27
股息收益率
-
股息
-

即将到来

收益

30Oct预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
0.01
0.14
0.26
0.39
预期每股收益
0.179857
实际每股收益
0.26

人们还关注

此列表基于关注STAA的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

43.33$平均价格目标
最高估值为 $55。
来自过去6个月内的 7 个评级。这不是投资建议。
买入
43%
持有
43%
卖出
14%

关于

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Show more...
首席执行官
Caren Mason
员工
1056
国家
US
ISIN
US8523123052

上市公司